Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
debts
Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
The debt refinancing and private placement represent Sarepta's latest move in a series of intensive measures to improve its financial position.
Angus Liu
Aug 21, 2025 10:52am
Bayer's corporate overhaul faces new questions after trial flop
Nov 21, 2023 4:37pm
Amicus scores $430M financing deal with asset manager Blackstone
Oct 2, 2023 4:16pm
Zevra is buying rare disease compatriot Acer for $91M
Aug 31, 2023 10:55am
In debt again, Glenmark seeks buyer for its API business: report
Apr 11, 2023 10:27am
Arcutis secures $225M ahead of critical year for topical tech
Jan 4, 2022 7:45am
